Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Int J Biol Macromol ; 267(Pt 2): 131510, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-38608989

RESUMO

Bacterial diseases caused substantial yield losses worldwide, with the rise of antibiotic resistance, there is a critical need for alternative antibacterial compounds. Natural products (NPs) from microorganisms have emerged as promising candidates due to their potential as cost-effective and environmentally friendly bactericides. However, the precise mechanisms underlying the antibacterial activity of many NPs, including Guvermectin (GV), remain poorly understood. Here, we sought to explore how GV interacts with Guanosine 5'-monophosphate synthetase (GMPs), an enzyme crucial in bacterial guanine synthesis. We employed a combination of biochemical and genetic approaches, enzyme activity assays, site-directed mutagenesis, bio-layer interferometry, and molecular docking assays to assess GV's antibacterial activity and its mechanism targeting GMPs. The results showed that GV effectively inhibits GMPs, disrupting bacterial guanine synthesis. This was confirmed through drug-resistant assays and direct enzyme inhibition studies. Bio-layer interferometry assays demonstrated specific binding of GV to GMPs, with dependency on Xanthosine 5'-monophosphate. Site-directed mutagenesis identified key residues crucial for the GV-GMP interaction. This study elucidates the antibacterial mechanism of GV, highlighting its potential as a biocontrol agent in agriculture. These findings contribute to the development of novel antibacterial agents and underscore the importance of exploring natural products for agricultural disease management.


Assuntos
Adenosina/análogos & derivados , Antibacterianos , Ivermectina , Antibacterianos/farmacologia , Antibacterianos/química , Ivermectina/farmacologia , Ivermectina/análogos & derivados , Ivermectina/química , Simulação de Acoplamento Molecular , Produtos Biológicos/farmacologia , Produtos Biológicos/química , Testes de Sensibilidade Microbiana , Carbono-Nitrogênio Ligases/metabolismo , Carbono-Nitrogênio Ligases/química , Carbono-Nitrogênio Ligases/antagonistas & inibidores , Inibidores Enzimáticos/farmacologia , Inibidores Enzimáticos/química , Mutagênese Sítio-Dirigida
2.
Plant Cell ; 33(12): 3675-3699, 2021 12 03.
Artigo em Inglês | MEDLINE | ID: mdl-34469582

RESUMO

Verticillium wilt is a severe plant disease that causes massive losses in multiple crops. Increasing the plant resistance to Verticillium wilt is a critical challenge worldwide. Here, we report that the hemibiotrophic Verticillium dahliae-secreted Asp f2-like protein VDAL causes leaf wilting when applied to cotton leaves in vitro but enhances the resistance to V. dahliae when overexpressed in Arabidopsis or cotton without affecting the plant growth and development. VDAL protein interacts with Arabidopsis E3 ligases plant U-box 25 (PUB25) and PUB26 and is ubiquitinated by PUBs in vitro. However, VDAL is not degraded by PUB25 or PUB26 in planta. Besides, the pub25 pub26 double mutant shows higher resistance to V. dahliae than the wild-type. PUBs interact with the transcription factor MYB6 in a yeast two-hybrid screen. MYB6 promotes plant resistance to Verticillium wilt while PUBs ubiquitinate MYB6 and mediate its degradation. VDAL competes with MYB6 for binding to PUBs, and the role of VDAL in increasing Verticillium wilt resistance depends on MYB6. Taken together, these results suggest that plants evolute a strategy to utilize the invaded effector protein VDAL to resist the V. dahliae infection without causing a hypersensitive response (HR); alternatively, hemibiotrophic pathogens may use some effectors to keep plant cells alive during its infection in order to take nutrients from host cells. This study provides the molecular mechanism for plants increasing disease resistance when overexpressing some effector proteins without inducing HR, and may promote searching for more genes from pathogenic fungi or bacteria to engineer plant disease resistance.


Assuntos
Proteínas de Arabidopsis/genética , Arabidopsis/fisiologia , Ascomicetos/fisiologia , Proteínas Fúngicas/genética , Doenças das Plantas/genética , Ubiquitina-Proteína Ligases/genética , Arabidopsis/genética , Arabidopsis/microbiologia , Proteínas de Arabidopsis/metabolismo , Ascomicetos/genética , Resistência à Doença/genética , Proteínas Fúngicas/metabolismo , Doenças das Plantas/microbiologia , Ubiquitina-Proteína Ligases/metabolismo
3.
Zhongguo Yi Liao Qi Xie Za Zhi ; 35(5): 386-8, 2011 Sep.
Artigo em Chinês | MEDLINE | ID: mdl-22242394

RESUMO

OBJECTIVE: To evaluate the clinical feasibility of daily quality assurance for linac radiation field by analyzing the trend of the daily testing data about parameter of radiation field. METHODS: Two-dimensional ion chamber array Daily QA3 was used to measure the difference between the practical value and the standard value of the parameter about radiation field before commencing daily treatment. Farmer type ionization chambers from IBA Co. with DOSE1 dosimeter was used for the absolute dosimetry of photon and electron beams. Light/radiation field coincidence was checked by using films every month. The daily testing data (from 11/28/2009 to 4/8/2011) were reviewed and analyzed. RESULTS: X-ray and electron output was increasing steadily; light/radiation field coincidence, beam flatness constancy and symmetry of X- ray and electron was keeping stable. CONCLUSION: The procedures for daily quality assurance of linac radiation field, which will provide reference for long term linac calibration, are feasible in our experience.


Assuntos
Aceleradores de Partículas , Radiometria/instrumentação , Radiometria/métodos , Estudos de Viabilidade , Controle de Qualidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA